Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,567 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- OncoTree
- BOWEL
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,298 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04672460 | A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors | completed | Phase 1 | 73 | PfizerINDUSTRY | 2 | Sep 25, 2024 | clinicaltrials |
| NCT05646030 | Feasibility, Reliability, and Satisfaction of CEA Using Home Based (Automated) Capillary Blood Sampling(CASA-I) | completed | N/A | 102 | Erasmus Medical CenterOTHER | 1 | Sep 25, 2024 |
| clinicaltrials |
| NCT03476707 | Association of Anemia With Hospital Costs in Elective Colorectal Surgery | completed | — | 851 | Ottawa Hospital Research InstituteOTHER | 0 | Sep 24, 2024 | clinicaltrials |
| NCT04713891 | A Study of KF-0210 in Advanced Solid Tumors Patients | completed | Phase 1 | 14 | Keythera Pharmaceuticals (Australia) Pty LtdINDUSTRY | 1 | Sep 24, 2024 | clinicaltrials |
| NCT04737187 | Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients(SUNLIGHT) | completed | Phase 3 | 492 | Taiho Oncology, Inc.INDUSTRY | 14 | Sep 24, 2024 | clinicaltrials |
| NCT01210313 | Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal Carcinoma | completed | — | 30 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Sep 19, 2024 | clinicaltrials |
| NCT01607957 | Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies(RECOURSE) | completed | Phase 3 | 800 | Taiho Oncology, Inc.INDUSTRY | 13 | Sep 19, 2024 | clinicaltrials |
| NCT03475004 | Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer | completed | Phase 2 | 53 | University of Colorado, DenverOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03853473 | Prehabilitation of Frail Surgical Cancer Patients Using Remote Ischemic Preconditioning(Prehab) | completed | N/A | 17 | Medical College of WisconsinOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT04474470 | A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer | completed | Phase 1 / Phase 2 | 52 | TyrNovo Ltd.INDUSTRY | 2 | Sep 19, 2024 | clinicaltrials |
| NCT05153746 | Adenoma Detection Rate of 3D Colonoscopy | completed | N/A | 318 | National Taiwan University HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05344950 | Connecting Audio and Radio Sensing Systems to Improve Care at Home(AURA) | completed | — | 13 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05611151 | Real-time Computer-Aided Detection of Colonic Adenomas With NEC WISE VISION® Endoscopy(COLOWISE) | completed | N/A | 830 | NEC CorporationINDUSTRY | 4 | Sep 19, 2024 | clinicaltrials |
| NCT06586307 | Estimating Lymphocyte Counts from DNA Methylation | completed | — | 49 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06597903 | A Monocentric Study to Investigate a New Low Dose Oral Gut Cleansing Solution | completed | Phase 2 | 36 | NorgineINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03800602 | Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer | completed | Phase 2 | 29 | Emory UniversityOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT02466009 | Regorafenib in Metastatic Colorectal Cancer | completed | Phase 2 | 27 | University of RochesterOTHER | 1 | Sep 4, 2024 | clinicaltrials |
| NCT02767986 | Where Culture Meets Genetics: Exploring Latinas Causal Attributions of Breast and Colon Cancer and Models of Disease Inheritance | completed | — | 22 | National Human Genome Research Institute (NHGRI)NIH | 1 | Sep 3, 2024 | clinicaltrials |
| NCT02860546 | A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC | completed | Phase 2 | 18 | Taiho Oncology, Inc.INDUSTRY | 1 | Sep 3, 2024 | clinicaltrials |
| NCT03263429 | Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer | completed | Phase 1 / Phase 2 | 29 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT02705300 | Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer | completed | Phase 2 | 70 | Vejle HospitalOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT02431676 | Survivorship Promotion In Reducing IGF-1 Trial(SPIRIT) | completed | Phase 2 | 121 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT04192071 | Virtual Human Delivered Nutrition Module for Colorectal Cancer Prevention | completed | N/A | 139 | University of FloridaOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT05875584 | Exploratory Study of a Novel Based rbcDNA Liquid Biopsy Technique for Colorectal Cancer Early Detection | completed | — | 598 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT02873195 | Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer | completed | Phase 2 | 133 | Academic and Community Cancer Research UnitedOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT03265483 | Magnesium Treatment on Vitamin D Metabolism in Participants Completed Personalized Prevention of Colorectal Cancer Trial | completed | N/A | 180 | Vanderbilt University Medical CenterOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT03267316 | A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors(CANFOUR) | completed | Phase 1 / Phase 2 | 167 | Cantargia ABINDUSTRY | 11 | Aug 22, 2024 | clinicaltrials |
| NCT03981614 | Binimetinib and Palbociclib or TAS-102 in Treating Patients With KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer | completed | Phase 2 | 102 | Academic and Community Cancer Research UnitedOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT05086627 | Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer | completed | Phase 2 | 118 | Hebei Medical University Fourth HospitalOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT00297791 | COLOR II: Laparoscopic Versus Open Rectal Cancer Removal(COLORII) | completed | Phase 3 | 1,044 | Nova Scotia Health AuthorityOTHER | 9 | Aug 21, 2024 | clinicaltrials |
| NCT06022887 | Time-Restricted Eating and Mindfulness-Based Stress Reduction to Reduce the Risk of Early-Onset Colorectal Cancer(MBSR&TRE) | completed | N/A | 43 | Lisa Tussing-HumphreysOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT02743221 | A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy(TASCO1) | completed | Phase 2 | 154 | Institut de Recherches Internationales ServierOTHER | 12 | Aug 20, 2024 | clinicaltrials |
| NCT06437691 | Effect of Stent Placement on Short Term Survival of Left Sided Obstructive Colorectal Cancers | completed | — | 65 | Yasir Musa Kesgin, MDOTHER | 0 | Aug 20, 2024 | clinicaltrials |
| NCT06561516 | Effects of Red Ginseng on Gastrointestinal Symptoms and Microbiota After Surgery for Gastrointestinal Cancer | completed | N/A | 60 | Gangnam Severance HospitalOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT04761783 | BESPOKE Study of ctDNA Guided Immunotherapy | completed | — | 290 | Natera, Inc.INDUSTRY | 1 | Aug 15, 2024 | clinicaltrials |
| NCT04067960 | Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer | completed | Early Phase 1 | 197 | Mayo ClinicOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT05130060 | A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer | completed | Phase 1 | 15 | Mayo ClinicOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT05662527 | Response to Immunotherapy in MMR-deficient Localized Colon Cancer(RESET-C) | completed | Phase 2 | 85 | Camilla QvortrupOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT03520946 | RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer Patients(RAMTAS) | completed | Phase 3 | 430 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT00788957 | Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC) | completed | Phase 1 / Phase 2 | 177 | NantBioScience, Inc.INDUSTRY | 0 | Aug 7, 2024 | clinicaltrials |
| NCT03133286 | Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)(RADIANT) | completed | — | 16 | DxTerity DiagnosticsINDUSTRY | 1 | Aug 7, 2024 | clinicaltrials |
| NCT06542354 | Prehabilitation During Neoadjuvant Chemoradiotherapy for Rectal Cancer | completed | N/A | 108 | Fudan UniversityOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT04166240 | Measuring and Improving the Safety of Test Result Follow-Up | completed | N/A | 46 | VA Office of Research and DevelopmentFED | 1 | Aug 6, 2024 | clinicaltrials |
| NCT03264898 | Comparative Effectiveness of FITs With Colonoscopy(BestFIT) | completed | — | 3,761 | Barcey T. LevyOTHER | 1 | Aug 2, 2024 | clinicaltrials |
| NCT06534242 | Implication of Genetic Variations in Long Intergenic Non-coding RNA 00511 (LINC00511) in Colorectal Cancer | completed | — | 400 | Ain Shams UniversityOTHER | 1 | Aug 2, 2024 | clinicaltrials |
| NCT06531902 | LncRNA Nicotinamide Nucleotide Transhydrogenase-Antisense RNA1 NNT-AS1 in CRC | completed | — | 88 | Ain Shams UniversityOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT05468593 | Patient Outcomes After Hepatic Artery Infusion Pump Placement | completed | — | 12 | Mayo ClinicOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT02848443 | Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer | completed | Phase 1 | 78 | Institut de Recherches Internationales ServierOTHER | 7 | Jul 25, 2024 | clinicaltrials |
| NCT03274882 | Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard Chemotherapies | completed | Phase 2 | 26 | Institut de Recherches Internationales ServierOTHER | 1 | Jul 25, 2024 | clinicaltrials |
| NCT03306394 | A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).(PRECONNECT) | completed | Phase 3 | 907 | Institut de Recherches Internationales ServierOTHER | 16 | Jul 25, 2024 | clinicaltrials |
Data updated 24 days agoSource updated Sep 25, 2024source: clinicaltrials